Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,679 Jan 1 – Oct 26, 2026
- Disclosed funding
- $339.5B 3662 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MT Develops therapies to halt fibrosis in multiple organ systems | $76M | Series B | Biotech | United States | Investors | |
| C CertHubCompany profile Uses AI-driven automation to accelerate medical device approvals and compliance Uses AI-driven automation to accelerate medical device approvals and compliance | €6.2M | Undisclosed | Healthtech | Germany | Investors | |
| PS Provides AI-native due diligence for life sciences dealmaking | $20M | Series A | Biotech | United States | Investors | |
| RM Rakuten MedicalCompany profile Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment | $100M | Series FSeries C+ | Biotech | United States | Investors | |
| H Provides AI-powered underwriting technology for mortgage lenders | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| SM Develops a Pulmonary Neuromodulation System for asthma treatment | $67M | Series A | Healthtech | United States | Investors | |
AIR Control ConceptsCompany profile AIR Control Concepts supports a network of commercial HVAC, electrical and controls businesses serving equipment manufacturers and their customers. AIR Control Concepts supports a network of commercial HVAC, electrical and controls businesses serving equipment manufacturers and their customers. | Undisclosed | Undisclosed | Proptech | United States | Investors | |
Develops AI-based digital biomarkers to support clinical diagnosis. | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| CH Corsera HealthCompany profile Develops preventive RNAi medicines for cardiovascular disease prediction and prevention Develops preventive RNAi medicines for cardiovascular disease prediction and prevention | $80M | Series A | Healthtech | United States | Investors | |
| T Provides technology-driven patient recruitment for clinical trials | Undisclosed | Strategic GrowthUndisclosed | Healthtech | Sweden | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Provision Labs, Tractian, Legora
101rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds8led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →